对突触的mRNA和circRNA错位是阿尔茨海默氏症疾病的关键特征
Samuel N Smukowski1,2, Cassidy Danyko1,3, Jenna Somberg1,4
1Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, WA, United States of America.
PLoS genetics
|July 29, 2024
概括
阿尔茨海默病破坏了RNA传输到突触,导致错位的mRNA和改变的循环RNA (circRNAs). 特定的circGSK3β异型会影响陶酸化,这表明circRNAs是AD的新型治疗点.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 突触RNA传输对神经元功能和可塑性至关重要.
- 阿尔茨海默病 (AD) 的特点是粉样质斑块,陶,和显著的突触损失.
- 阿尔茨海默病对突触内RNA局部化的影响在很大程度上仍未被探索.
研究的目的:
- 为了研究阿尔茨海默病中RNA突触局部化的变化.
- 为了确定特定的信使RNAs (mRNAs) 和循环RNAs (circRNAs) 被AD影响在突触.
- 探索改变circRNA表达对陶酸化的功能后果.
主要方法:
- RNA测序在阿兹海默症患者和健康对照者的突触体和大脑同质体上进行.
- 对人类样本和AD.的APPswe/PSEN1dE9小鼠模型进行了分析.
- 用神经细胞培养物来评估特定circRNA异型对陶酸化的影响.
主要成果:
- 发现数百个mRNAs在AD大脑 (额头和部区域) 的突触中被错位.
- 在AD中观察到突触circRNA配置文件的显著差异,包括circGSK3β异型的独特表达模式.
- 特定circGSK3β异型的上调和下调与神经元细胞中改变的陶酸化相关.
结论:
- 阿尔茨海默氏症严重影响了突触内mRNAs的局部化.
- 循环RNAs,特别是circGSK3β异型,通过影响陶酸化,在AD病变发生过程中发挥作用.
- 这些发现突出了circRNAs作为阿尔茨海默病潜在治疗点的新型类别.
相关概念视频
Regulated mRNA Transport
6.3K
In eukaryotes, transcription and translation are compartmentalized; an mRNA is first synthesized in the nucleus and then selectively transported to the cytoplasm for protein synthesis. Before transport, a pre-mRNA undergoes several steps of post-transcriptional modifications including splicing, 5' capping, and the addition of a poly-adenine tail. Various proteins bind to the pre-mRNA during these modifications. The mRNA transport takes place with the help of multiple proteins playing...
6.3K
RNA Editing
9.0K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.0K
Nuclear Export of mRNA
7.6K
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
7.6K
Alzheimer's Disease: Overview
456
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456
Nonsense-mediated mRNA Decay
10.6K
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
10.6K
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K


